Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-29 16:34:10 - browse：68

Who polices algorithms? How would you name the first approved CRISPR medicine? And what pairs well with a biotech downturn?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Casey Ross joins us to tell the bombshell story of how the nation’s largest health insurer used a computer algorithm to deny patient care and boost its profitability. Then, biotech veteran Michael Gilman calls in to offer a behind-the-scenes peek at what it’s like to be a startup CEO in this economic downturn — and which cocktail recipes help make it bearable. We also discuss a pioneering approval for a genome-editing medicine.

For more on what we cover, here’s the UnitedHealth story; here’s more on the CRISPR approval; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Why the world’s most expensive drug might be worth the price

explore

WSS

Medicare drug price negotiation’s day in court

The real point of Kenneth Smith’s execution by nitrogen gas

Do digital therapeutics have a future in medicine?

FDA drug safety: Singulair case shows systemic surveillance flaws

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Eliminate the waiting period for sterilization covered by Medicaid

leisure time

Wikipedia

explore

Hollywood unions extend contract negotiations for actors

Oprah kicked off a national conversation on obesity. Let's have it

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

BioMarin wins approval for gene therapy to treat hemophilia A

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Hepatitis C has a cure — but many Americans still lack access to it

Eliminate the waiting period for sterilization covered by Medicaid

focus

General Catalyst, Summa Health deal will turn on physician buy

Primary care physicians play key roles in Alzheimer's management

There's no autism epidemic. It's an autism diagnosis epidemic

Do digital therapeutics have a future in medicine?

Why the world’s most expensive drug might be worth the price

States should stop sabotaging methadone treatment reform

explore

entertainment

explore

leisure time